Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : ADOT - BIOMODA: Profitable Technology with Purpose -- Ignore unavailable to you. Want to Upgrade?

To: JOHN WHITE who wrote (1568)	9/9/1998 10:05:00 AM
From: Archie Goodwin	Read Replies (1) \| Respond to of 4650

News........... (BSNS WIRE) Advanced Optics Electronics to Increase Production Capacity; Advanced Optics Electronics to Increase Production Capacity; Company Has Qualified Buyers for Seven Additional Displays Totaling $7 Million Business Editors & Health/Medical Writers ALBUQUERQUE, N.M.--(BUSINESS WIRE)--Sept. 9, 1998--Advanced Optics Electronics, Inc. (OTC BB: ADOT) today announced the Company is gearing up for assembly-type production of its display systems by adding key technical personnel to the production team. Advanced Optics currently has contracts for two flat-panel displays that are now being fitted with satellite communications systems as requested by the buyers. The Company has recently pre-qualified several buyers for seven additional large-scale, flat-panel displays and will announce each of these contracts as they are formalized and signed. Advanced Optics also announced it intends to create a marketing department in January to market the Company's products and handle the growing list of requests for the Company's flat-panel displays. In other news, Biomoda, Inc. (of which Advanced Optics owns approximately 22% with an option to increase its holdings to 27%) recently informed Advanced Optics that LungCheck(R), Inc. of Scottsdale, Ariz. has nearly completed its blind study of Biomoda's test for the early detection of lung cancer. These results will be sent for confirmation to a prestigious institution on the East coast, with further confirmation expected by the first week in October. Verified results will be submitted to various medical journals for publication. Upon receipt of the test results from LungCheck, Biomoda expects to open formal negotiations with several major pharmaceutical and medical technology companies including SCHERING AG/Berlex, a German-based company with over $3.8 Billion ($U.S.) in annual revenues and offices world-wide. Schering AG/Berlex specializes in early diagnostics and therapy, two key areas addressed in Biomoda's cancer testing and treatment program. Preliminary discussions had previously been held between representatives of Berlex Labs in Wayne, N.J. and representatives of Biomoda, Inc. This press release contains forward-looking statements with respect to the results of operations, expectations and business of the Company that involves risk and uncertainties. The Company's actual future results could materially differ from those discussed. Risks and uncertainties of the Company will be detailed from time to time in the Company's periodic reports to be filed with the Securities and Exchange Commission. ADVANCED OPTICS COMPANY INFORMATION Advanced Optics Electronics, Inc. (OTC Bulletin Board: ADOT - news) is a developer of patented electronic display technology, utilizing ADOT's proprietary SLM (Spatial Light Modulator) light valve. This industry-leading technology can be utilized in many diverse fields including the production of "television quality" advertising billboards, medical testing equipment, military displays, computer monitors and high definition video transmission. Advanced Optics Electronics actively seeks partnerships with companies in fields that could benefit from ADOT's patented technology. ADOT also owns approximately 22% of Biomoda, Inc., an emerging biotechnology company specializing in breakthrough cancer diagnostics and therapy. Advanced Optics Electronics, Inc. has retained first right of refusal to design, manufacture and distribute the necessary scanning testing devices for the lung cancer tests using Advanced Optics Electronics' proprietary display technology. Contact Advanced Optics Electronics, Inc. at 505/797-7878 Web site: adot.org. --30--LS/na* CONTACT: Advanced Optics Electronics Inc., Albuquerque 505/797-7878 adot.org KEYWORD: NEW MEXICO NEW YORK ARIZONA NEW JERSEY INDUSTRY KEYWORD: BIOTECHNOLOGY MEDICINE PHARMACEUTICAL TELECOMMUNICATIONS COMPUTERS/ELECTRONICS COMED AEROSPACE/DEFENSE Today's News On The Net - Business Wire's full file on the Internet with Hyperlinks to your home page. URL: businesswire.com * end of story * Brian $^)

To: JOHN WHITE who wrote (1568)	9/9/1998 10:07:00 AM
From: dexx	Respond to of 4650

ADOT News out on Business Wire Advanced Optics Electronics to Increase Production Capacity Company Has Qualified Buyers for Seven Additional Displays Totaling $7 Million ALBUQUERQUE, N.M.--(BUSINESS WIRE)--September 9, 1998--Advanced Optics Electronics, Inc. (OTC BB: ADOT) today announced the Company is gearing up for assembly-type production of its display systems by adding key technical personnel to the production team. Advanced Optics currently has contracts for two flat-panel displays that are now being fitted with satellite communications systems as requested by the buyers. The Company has recently pre-qualified several buyers for seven additional large-scale, flat-panel displays and will announce each of these contracts as they are formalized and signed. Advanced Optics also announced it intends to create a marketing department in January to market the Company's products and handle the growing list of requests for the Company's flat-panel displays. In other news, Biomoda, Inc. (of which Advanced Optics owns approximately 22% with an option to increase its holdings to 27%) recently informed Advanced Optics that LungCheck(R), Inc. of Scottsdale, AZ has nearly completed its blind study of Biomoda's test for the early detection of lung cancer. These results will be sent for confirmation to a prestigious institution on the East coast, with further confirmation expected by the first week in October. Verified results will be submitted to various medical journals for publication. Upon receipt of the test results from LungCheck, Biomoda expects to open formal negotiations with several major pharmaceutical and medical technology companies including SCHERING AG/Berlex, a German-based company with over $3.8 Billion ($U.S.) in annual revenues and offices world-wide. Schering AG/Berlex specializes in early diagnostics and therapy, two key areas addressed in Biomoda's cancer testing and treatment program. Preliminary discussions had previously been held between representatives of Berlex Labs in Wayne, NJ and representatives of Biomoda, Inc. This press release contains forward-looking statements with respect to the results of operations, expectations and business of the Company that involves risk and uncertainties. The Company's actual future results could materially differ from those discussed. Risks and uncertainties of the Company will be detailed from time to time in the Company's periodic reports to be filed with the Securities and Exchange Commission. ADVANCED OPTICS COMPANY INFORMATION Advanced Optics Electronics, Inc. (OTC Bulletin Board: ADOT - news) is a developer of patented electronic display technology, utilizing ADOT's proprietary SLM (Spatial Light Modulator) light valve. This industry-leading technology can be utilized in many diverse fields including the production of "television quality" advertising billboards, medical testing equipment, military displays, computer monitors and high definition video transmission. Advanced Optics Electronics actively seeks partnerships with companies in fields that could benefit from ADOT's patented technology. ADOT also owns approximately 22% of Biomoda, Inc., an emerging biotechnology company specializing in breakthrough cancer diagnostics and therapy. Advanced Optics Electronics, Inc. has retained first right of refusal to design, manufacture and distribute the necessary scanning testing devices for the lung cancer tests using Advanced Optics Electronics' proprietary display technology. Contact Advanced Optics Electronics, Inc. at (505) 797-7878